With 0.1 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.2 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.45 whereas the lowest price it dropped to was $6.75. The 52-week range on NTHI shows that it touched its highest point at $25.00 and its lowest point at $3.20 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NTHI was up-trending over the past week, with a rise of 27.41%, but this was up by 51.33% over a month.
Float and Shares Shorts:
At present, 19.03 million NTHI shares are outstanding with a float of 4.24 million shares on hand for trading. On 2025-08-15, short shares totaled 0.17 million, which was 88.0 higher than short shares on 1752537600. In addition to Dr. Thomas C. Chen M.D., Ph.D. as the firm’s Founder, CEO, Chief Scientific Officer & Director, Mr. Keithly A. Garnett serves as its CFO & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, NTHI reported revenue of $0.0 and operating income of -$5708034.0. The EBITDA in the recently reported quarter was -$5631420.0 and diluted EPS was -$0.3.
